Form 4 for REPL Replimune Group, Inc.
Accepted 2023-07-11 00:00:00 ET · period of report 2023-07-10 · accession 0001104659-23-080113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-11 | 2023-07-10 | REPL | Esposito Pamela | Chief Business Off | S - Sale+OE | $21.58 | -20.0K | 263.4K | -7% | -$431.5K |
| DM | 2023-07-11 | 2023-07-10 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $6.35 | +20.0K | 278.4K | +8% | +$127.0K |
| DM | 2023-07-11 | 2023-07-10 | REPL | Esposito Pamela | Chief Business Off | M - OptEx | $0.00 | -20.0K | 106.7K | -16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-10 | S | D | 17,923 | $21.63 | 265,513 | D | — | — | (F2) The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.18 to $22.17. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| 2 | Common | Common Stock | 2023-07-10 | M | A | 5,000 | $15.50 | 283,436 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-10 | M | A | 15,000 | $3.30 | 278,436 | D | — | — | |
| 4 | Common | Common Stock | 2023-07-10 | S | D | 2,077 | $21.12 | 263,436 | D | — | — | (F3) The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.09 to $21.17. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F4) Following the sales reported on this Form 4, the reporting person continues to beneficially own 263,436 shares of the Issuer's common stock. The reporting person also holds options to acquire an aggregate of 517,227 shares of the Issuer's common stock, 395,314 of which are exercisable as of the date hereof. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2023-07-10 | M | D | 5,000 | $0.00 | 40,750 | D | $15.50 · — to 2029-04-01 | 5,000 Common Stock | (F6) The reporting person was granted an option to purchase 75,750 shares of the Issuer's common stock on April 1, 2019. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-07-10 | M | D | 15,000 | $0.00 | 106,691 | D | $3.30 · — to 2027-07-26 | 15,000 Common Stock | (F5) The reporting person was granted an option to purchase 134,281 shares of the Issuer's common stock on July 26, 2017. All of the shares underlying such stock option have vested and are exercisable as of the date hereof. |